RNATX 2023
The inaugural Swiss RNA Therapeutics Summit brought academia, biotechnology and pharma together in Bern.
Keynote speakers
Mustafa Diken
BioNTech · “mRNA based vaccines and beyond”
Shalini Andersson
AstraZeneca · “Developing Next Generation Oligonucleotide Therapeutics”
Program
Open a session to view its speakers and details.
08:30 Welcome coffee
09:15 Opening remarks & welcome address
Christian Leumann · Rector, University of Bern
09:30 Keynote I · Mustafa Diken
“mRNA based vaccines and beyond” · Chair: Jonathan Hall
10:10 Company presentations I
Mario Jauker · Bachem
Torsten Schmidt · Lonza
Soham Mandal · Axolabs
Nicolas Chornet · Moderna
11:10 Coffee break
11:40 Panel · RNA therapeutics in Switzerland
Mustafa Diken · Oliver Mühlemann · Nicole Schaad · Volker Thiel
Moderator: Dominik Theler
12:25 Company talent presentations
Daniel Wanner · Cédric Vonarburg · Dmitry Kopelyanskiy · Theo Rowley · Erich Koller · Stefan Reber · Klaas Zuideveld
13:00 Lunch & meet the talent
14:15 Keynote II · Shalini Andersson
“Developing Next Generation Oligonucleotide Therapeutics” · Chair: Jonathan Hall
14:55 Investor panel
Bettina Ernst · Gabriela Ecco · Klaas Zuideveld
Moderator: Carsten Laue
15:30 Coffee break
16:00 Company presentations II
Tom Edwardson · Riccardo Dainese · Stefanie Urlinger · Daniel Blessing · Friedrich Metzger
16:50 Swiss regulatory aspects
Julia Djonova · Swissmedic
17:05 Panel · Technological trends & needs
Shalini Andersson · Julia Djonova · Lukas Jeker · Markus Stoffel
Moderator: Jonathan Hall
18:00 Apéro
Speakers & partners
The people and organizations behind the first edition.
2023 sponsors
| Time | Session |
|---|---|
| 08:30 | Welcome Coffee |
| 09:15 | Opening Remarks |
| 09:20 | Welcome Address: Christian Leumann – Rector of the University of Bern |
| 09:30 | Keynote I: Mustafa Diken – Vice President of Vaccines & Immunology, BioNTech – “mRNA based vaccines and beyond” (Chair: Jonathan Hall) |
| 10:10 | Company Presentations I: Mario Jauker – Bachem Torsten Schmidt – Lonza Soham Mandal – Axolabs Nicolas Chornet – Moderna |
| 11:10 | Coffee Break Sponsored by: |
| 11:40 | Panel I – RNA Therapeutics in Switzerland: How to Join Forces: Mustafa Diken – BioNTech Oliver Mühlemann – University of Bern & Director NCCR RNA & Disease Nicole Schaad – State Secretariat for Education, Research and Innovation Volker Thiel – EDI & University of Bern, Swiss National COVID-19 Science Task Force Moderated by Dominik Theler |
| 12:25 | Company Talent Presentations: Daniel Wanner – Bachem Cédric Vonarburg – CSL Behring Dmitry Kopelyanskiy – Haya Theo Rowley – Moderna Erich Koller – Roche Stefan Reber – Skyhawk Versameb – Klaas Zuideveld |
| 13:00 | Lunch & Meet the Talent Session Lunch sponsored by: |
| 14:15 | Keynote II: Shalini Andersson – Vice President Oligonucleotide Discovery, AstraZeneca – “Developing Next Generation Oligonucleotide therapeutics” (Chair: Jonathan Hall) |
| 14:55 | Panel II: Investors Bettina Ernst – Bernina BioInvest Gabriela Ecco – +ND Capital Klaas Zuideveld – Versameb Moderated by Carsten Laue |
| 15:30 | Coffee Break Sponsored by:  |
| 16:00 | Company Presentations II: Tom Edwardson – Procavea Riccardo Dainese – Alithea Genomics Stefanie Urlinger – Cimeio Daniel Blessing – Haya Friedrich Metzger – Versameb |
| 16:50 | Swiss Regulatory Aspects – Julia Djonova – Swissmedic |
| 17:05 | Panel III – Technological Trends & Needs Shalini Andersson – VP Oligonucleotide Discovery, AstraZeneca Julia Djonova – Swissmedic Lukas Jeker – University of Basel & co-founder Cimeio Markus Stoffel – ETH Zurich & SAB Alnylam Moderated by Jonathan Hall |
| 17:50 | Concluding Remarks |
| 18:00 | Apéro sponsored by the Bern Economic Development Agency  |
| | |
- Shalini Andersson – AstraZeneca
- Daniel Blessing – Haya
- Nicolas Chornet – Moderna
- Riccardo Dainese – Alithea Genomics
- Mustafa Diken – BioNTech
- Julia Djonova – Swissmedic
- Gabriela Ecco – +ND Capital
- Tom Edwardson – Procavea Biotech
- Bettina Ernst – Bernina Biotech
- Mario Jauker – Bachem
- Lukas Jeker – University of Basel, Cimeio Therapeutics
- Erich Koller – Roche
- Dmitry Kopelyanskiy – Haya
- Christian Leumann – University of Bern
- Soham Mandal – Axolabs
- Friedrich Metzger – Versambeb
- Oliver Mühlemann – Director NCCR RNA & Disease & University of Bern
- Stefan Reber – Skyhawk
- Theo Rowley – Moderna
- Nicole Schaad – State Secretariat for Education, Research and Innovation
- Torsten Schmidt – Lonza
- Markus Stoffel – ETH Zürich & Alnylam Pharmaceuticals
- Volker Thiel – IVI, EDI and Universty of Bern
- Stefanie Urlinger – Cimeio
- Cédric Vonarburg – CSL Behring
- Daniel Wanner – Bachem
- Klaas Zuideveld – Versameb
Let’s keep the conversation going.
Have a question about the Summit, registration or sponsorship? Get in touch with the RNATX team or follow us for the latest program announcements.